More than 50% of people who will suffer a heart attack – the most common cause of death in both men and women – will do so without experiencing any symptoms. Our team at Cleerly has spent more than a decade performing some of the largest clinical trials to identify important findings beyond symptoms that increase a person’s risk of heart attacks.
Cleerly Coronary* goes beyond traditional measures of heart disease by enabling comprehensive quantification and characterization of plaque buildup in each of the heart arteries. The findings from Cleerly Coronary support the identification of plaques that may cause heart attacks.
Identification of the features of plaques that may cause heart attacks has been very difficult using traditional methods. Cleerly Coronary’s* non-invasive, AI-driven approach supports the understanding of plaques using FDA-cleared technologies.
Cleerly Coronary’s* multi-level data visualization platform aims to improve understanding of heart disease for both basic and advanced users. Navigate the Centerpiece to better understand each important feature of coronary artery disease.
Enrich health literacy with patient-facing educational solutions, viewable anywhere.
Support the diagnosis, prognostication and clinical decision making of coronary artery disease with comprehensive tools.
Cleerly Coronary* results are delivered in as little as 1 hour so you can spend more time with patients.
The goal of Cleerly Coronary* is to serve as a central component of an image-based care paradigm that improves understanding and education of heart disease, and supports each of the stakeholders in the care pathway, including imaging physicians, clinicians and patients.
To create a new standard of care for coronary artery disease that can help prevent the millions of heart attacks that occur worldwide every year.
Cleerly Coronary’s* advanced analysis augments traditional measures of heart health evaluation to identify disease early, when heart attacks can be prevented.
Please contact us to learn more.